SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Holdings is seeing intense community speculation as investors position for a high-stakes earnings release, with many betting that a positive surprise will trigger a short squeeze given the stock's significant short interest. Discussion is dominated by expectations for robust revenue growth and potential guidance hikes, while retail traders remain sharply divided between those bracing for extreme volatility and those holding for a long-term breakout.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is experiencing a massive short squeeze and surge in investor interest following a strong earnings report that showcased significant revenue growth and high-demand cloud infrastructure contracts. Investors are actively debating the stock's parabolic move, with many cheering the aggressive gains while criticizing vocal short sellers who have reportedly doubled down on their bearish positions.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is experiencing high volatility as investors weigh its aggressive growth partnerships against concerns over valuation, heavy insider selling, and significant upcoming share lockup expirations. The community remains deeply divided, with some traders actively buying the dip based on the company's AI infrastructure potential, while others argue the stock remains overpriced and vulnerable to further downside.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is currently the focal point of intense community discussion as investors anticipate strong earnings results, fueled by significant institutional accumulation and positive momentum across the quantum sector. Traders are closely monitoring the company's progress on scaling logical qubits and its expanding pipeline of government and commercial contracts, viewing the stock as a high-potential, albeit speculative, player in the long-term quantum computing landscape.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco Systems is attracting significant investor attention following a strong earnings report and raised forward guidance, as the company increasingly benefits from critical networking and infrastructure spending tied to the AI supercycle. The community remains focused on whether the stock can sustain its momentum toward higher price targets despite recent volatility, with active discussions weighing the company's long-term enterprise growth against broader sector valuations.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

TSLL is currently attracting heavy retail interest as traders bet on a rebound following significant price volatility in Tesla, with many in the community actively discussing strategies to buy the dip or hedge positions through covered calls. Investors are focused on the tension between short-term technical oversold signals and broader questions regarding Tesla's valuation, potential SpaceX-related synergies, and the impact of frequent options market dynamics on the stock's movement.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar is experiencing heightened market speculation as investors focus on potential short-squeeze activity, institutional accumulation, and the company's strategic shift toward U.S. manufacturing. The community is actively debating the stock's valuation relative to its industry peers, with many calling for management to address what they perceive as significant share price manipulation and a disconnect between the company's fundamentals and its market performance.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is trending as investors look toward upcoming earnings amid a broader retail recovery, with the community actively debating the company's turnaround progress and potential for further upside. Speculation remains high regarding the stock's defensive strength, dividend reliability, and the sustainability of recent price momentum as market participants position themselves ahead of the next financial report.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is gaining significant momentum and attention following the announcement of a massive binding 15-year data center lease with TensorWave, which is bolstered by a strategic alliance with Hillcore Energy. The community is actively discussing these infrastructure milestones, the appointment of a seasoned new CEO, and the company's emergence as a key player in AI-focused energy capacity, leading to speculation about potential future hyperscale tenant deals and institutional upgrades.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending as investors weigh significant robotaxi investment plans against a Q3 earnings forecast that fell short of analyst expectations. The community remains divided, with many focusing on the long-term potential of its autonomous vehicle partnerships and advertising business, while others express frustration over recent price volatility and concerns regarding competitive pressure from robotaxi rivals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oppenheimer reit&#39;d $URGN OP; $40 
$CGON $TYRA  
Oppenheimer said: 
UroGen&#39;s investor event reinforced the commercial thesis for Zusduri in LG-IR-NMIBC, with the physician panel framing the drug as a potential paradigm shift from repeated surgeries (TURBT) toward office-based chemoablation. 
 
The most important incremental message was the degree of physician enthusiasm around broad use beyond the obvious advantages of avoiding repeated surgery. Doctors described Zusduri as easy to integrate operationally, increasingly reimbursable after permanent J-code implementation, patient-friendly relative to TURBT and conventional intravesical chemo, and appropriate for consideration among essentially all eligible recurrent patients. 
 
The panel also suggested that future competitors may face meaningful positioning hurdles unless they can offer overwhelmingly better efficacy, as Zusduri is first-to-market, requires no biomarker testing, can be used without TURBT, and has a finite six-dose treatment course.

khpower

Oppenheimer⬆️ $URGN&#39;s PT  to $34 from $31 and reiterated at an Outperform rating. 
$CGON $TYRA $MRK LLY $IBRX 
Oppenheimer said—Zusduri 4Q sales of $14M essentially matched consensus, but were nearly double our $7.5M estimate on our pre-J code conservatism. 
 
On its conference call, management expressed comfort with 2026 consensus (which we later clarified as ~$125M) and reported that, in the February month, key indicators tracked above those for Jelmyto (~$100M/yr). 
 
Lifecycle extension development programs to both products are proceeding on pace, with UGN-103 heading toward anticipated LG-IR-NMIBC approval 
next year. 
 
The favorable fundamentals notwithstanding, shares were weak off the print—perhaps the market was looking for more current-quarter objective launch metrics beyond the narrative. In any event, we like the entry at these levels and expect Zusduri sales growth to drive outperformance. Reiterate Outperform and raise PT to $34 (from $31).

StockTwits Web

UroGen Pharma Ltd

Cg Oncology Inc.

Tyra Biosciences Inc

Merck & Co Inc

ImmunityBio Inc

Quantumup

  
Oppenheimer said: 
UroGen's investor event reinforced the commercial thesis for Zusduri in LG-IR-NMIBC, with the physician panel framing the drug as a potential paradigm shift from repeated surgeries (TURBT) toward office-based chemoablation. 
 
The most important incremental message was the degree of physician enthusiasm around broad use beyond the obvious advantages of avoiding repeated surgery. Doctors described Zusduri as easy to integrate operationally, increasingly reimbursable after permanent J-code implementation, patient-friendly relative to TURBT and conventional intravesical chemo, and appropriate for consideration among essentially all eligible recurrent patients. 
 
The panel also suggested that future competitors may face meaningful positioning hurdles unless they can offer overwhelmingly better efficacy, as Zusduri is first-to-market, requires no biomarker testing, can be used without TURBT, and has a finite six-dose treatment course.